Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease: Cochrane systematic review

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease: Cochrane systematic review ID - 435308 PB - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435308/all/Intravenous_alpha_1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha_1_antitrypsin_deficiency_and_lung_disease:_Cochrane_systematic_review ER -